GB0105613D0 - Pharmaceutically effective compounds and their use - Google Patents

Pharmaceutically effective compounds and their use

Info

Publication number
GB0105613D0
GB0105613D0 GBGB0105613.4A GB0105613A GB0105613D0 GB 0105613 D0 GB0105613 D0 GB 0105613D0 GB 0105613 A GB0105613 A GB 0105613A GB 0105613 D0 GB0105613 D0 GB 0105613D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutically effective
effective compounds
compounds
pharmaceutically
effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0105613.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge University Technical Services Ltd CUTS
Original Assignee
Cambridge University Technical Services Ltd CUTS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge University Technical Services Ltd CUTS filed Critical Cambridge University Technical Services Ltd CUTS
Priority to GBGB0105613.4A priority Critical patent/GB0105613D0/en
Publication of GB0105613D0 publication Critical patent/GB0105613D0/en
Priority to AU2001275707A priority patent/AU2001275707A1/en
Priority to PCT/GB2001/003360 priority patent/WO2002007732A2/en
Priority to AU2002234773A priority patent/AU2002234773A1/en
Priority to PCT/GB2002/000891 priority patent/WO2002069980A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0105613.4A 2000-07-26 2001-03-07 Pharmaceutically effective compounds and their use Ceased GB0105613D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0105613.4A GB0105613D0 (en) 2001-03-07 2001-03-07 Pharmaceutically effective compounds and their use
AU2001275707A AU2001275707A1 (en) 2000-07-26 2001-07-26 Use of panaxatriol for stimulation angiogenesis
PCT/GB2001/003360 WO2002007732A2 (en) 2000-07-26 2001-07-26 Use of panaxatriol for stimulation angiogenesis
AU2002234773A AU2002234773A1 (en) 2001-03-07 2002-03-01 Pharmaceutically effective ginsenosides and their use
PCT/GB2002/000891 WO2002069980A2 (en) 2001-03-07 2002-03-01 Pharmaceutically effective ginsenosides and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0105613.4A GB0105613D0 (en) 2001-03-07 2001-03-07 Pharmaceutically effective compounds and their use

Publications (1)

Publication Number Publication Date
GB0105613D0 true GB0105613D0 (en) 2001-04-25

Family

ID=9910153

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0105613.4A Ceased GB0105613D0 (en) 2000-07-26 2001-03-07 Pharmaceutically effective compounds and their use

Country Status (3)

Country Link
AU (1) AU2002234773A1 (en)
GB (1) GB0105613D0 (en)
WO (1) WO2002069980A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002038166A2 (en) * 2000-11-07 2002-05-16 University Of Chicago Ginseng berry extracts and pharmaceutical compositions therefrom
DE10158281A1 (en) * 2001-11-19 2003-05-28 Mediwirk Gmbh Pharmaceutical preparation comprises ginsenoside enclosed in micro-shell, e.g. liposome, providing targeted and controlled delivery, useful e.g. in treatment of liver tumors, diabetes mellitus or hypertension
MXPA05013844A (en) 2003-06-23 2006-07-06 Geron Corp Compositions and methods for increasing telomerase activity.
WO2005000248A2 (en) 2003-06-25 2005-01-06 Geron Corporation Compositions and methods for skin conditioning
GB0513881D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0513883D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
CN102391345B (en) * 2011-10-25 2012-10-31 吉林大学 Pseuoginsenoside-Rh 2 and application in preparation of tumor treating medicine
KR102158201B1 (en) 2017-04-07 2020-09-21 주식회사 세라젬 Thermo-therapeutic appratus and method for controlling the same
CN112898371B (en) * 2021-03-20 2022-03-29 延边大学 Panaxatriol compounds, preparation method and medical application thereof
CN115444612A (en) * 2021-04-02 2022-12-09 苏州大学 Barbed silk suture line

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684628A (en) * 1985-05-03 1987-08-04 Yaguang Liu Pharmaceutical composition containing pure San-Mai-Sen
US4755504A (en) * 1985-10-03 1988-07-05 Yaguang Liu Pharmaceutical composition from Tienchi
GB9024895D0 (en) * 1990-11-15 1991-01-02 Erba Carlo Spa Therapeutic use of fibroblast growth factor
FR2695561B1 (en) * 1992-09-17 1994-12-02 Lvmh Rech Gie Cosmetic or dermatological composition containing at least one ginsenoside-type saponin, and its applications, in particular for hair care.
US5891465A (en) * 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth
JPH1036388A (en) * 1996-07-25 1998-02-10 Kureha Chem Ind Co Ltd Synthesis inhibitor containing ginsenoside of protein belonging to hsp 27 family
JP2000191539A (en) * 1998-12-22 2000-07-11 Japan Science & Technology Corp BRAIN CELL OR NERVE CELL-PROTECTING AGENT COMPRISING GINSENOSIDE Rb1
JP2000302798A (en) * 1999-02-19 2000-10-31 Japan Science & Technology Corp PROMOTER FOR CEREBRAL BLOOD VESSEL REPRODUCTION/ RESTRUCTURING AND INHIBITOR AGAINST SECONDARY NERVE TISSUE SECONDARY DENATURATION COMPRISING GINSENOSIDE Rb1
KR20020035855A (en) * 1999-08-30 2002-05-15 마쯔오 미쯔요시 Brain cell or nerve cell protecting agents comprising ginseng
JP2002322068A (en) * 2001-02-26 2002-11-08 Japan Science & Technology Corp Vascular regeneration promoter

Also Published As

Publication number Publication date
WO2002069980A3 (en) 2004-04-15
WO2002069980A2 (en) 2002-09-12
AU2002234773A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
TWI316062B (en) Anti-inflammatory compounds and uses thereof
EP1423120A4 (en) 2h-phthalazin-1-ones and methods for use thereof
HK1068555A1 (en) New formulations and use thereof
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
EP1434772A4 (en) Compounds and methods
HUP0401756A3 (en) Substituted benzimidazole compounds and their use
HK1069385A1 (en) Heterocyclic compound and medicinal use thereof
GB0105613D0 (en) Pharmaceutically effective compounds and their use
AU2002359694A8 (en) Compounds and methods
GB0126889D0 (en) Compounds and their uses
GB0119025D0 (en) Compounds and their therapeutic use
GB0021497D0 (en) Compounds and their use
GB0007530D0 (en) Trityl-type compounds and their use
GB0018887D0 (en) Compound and their therapeutic use
EP1379240A4 (en) Compounds and methods
EP1367123A4 (en) Neurotonin and use thereof
GB2376943B (en) Compounds and their therapeutic use
GB0112237D0 (en) Compounds and their therapeutic use
GB0200843D0 (en) Benzodioxinopyrroles their preparation and use
GB0018388D0 (en) Pharmaceutically effective compounds and their use
AU2002356679A8 (en) Clusianon isomers and use thereof
GB0128122D0 (en) Therapeutic use
GB0128138D0 (en) Pharmaceutical use
GB0201615D0 (en) Compounds and their therapeutic use
GB0128512D0 (en) Compounds and their therapeutic use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)